7 - 9 December 2017 International Convention Centre (ICC) Sydney

The VERVE Symposium in conjunction with LINC Australia program will incorporate a world renowned international faculty, with live cases from the University Hospital in Leipzig, Prince of Wales Private Hospital Sydney and the Mater Hospital Sydney. We are introducing a call for abstracts in the categories of original scientific research and challenging cases with a chance for individuals to join the faculty for a podium or e-poster presentation, providing endovascular techniques, peripheral, carotid, aortic and late breaking trial data and the opportunity for individuals to present their research.

ENDOVASCULAR MASTERCLASS AND GLOBAL EXPERT DISCUSSION FORUM

*Program subject to change

Thursday 7 December 2017   Venue: International Convention Centre

Vascular Ultrasound Meeting
Venue: Parkside Ballroom – Level 2
8:30 – 10:00 am
Session A: Vascular Ultrasound Challenges in Peripheral Interventions and Venous
Chairs: R. Varcoe, B. Bourke
8.30 – 8.35
Introductory Remarks: Ramon Varcoe
8.35 – 8.45
How I Use Ultrasound to Maximise Success in Peripheral Interventions
Presenter: Jihad Mustapha
8.45 – 8.55
Routine Use of Ultrasound Guidance and Micropuncture Makes Endovascular Access Safer
Presenter: Peter Schneider
8.55 – 9.05
Ultrasound Guidance to Assist Crossing of Chronic Total Occlusions in Femoropopliteal Arteries
Presenter: Ian Spark
9.05 – 9.15
The Importance of Thorough Calf Artery Assessment with Duplex Ultrasound – Before and After Intervention
Presenter: David Robinson
9.15 – 9.25
Case study – Cannabis Induced Arteritis in a 19 year old
Presenter: Nathan Campbell
9.25 – 9.35
The Underestimated Role of Duplex Ultrasound in Identifying May Thurner syndrome
Presenter: Peter Sharman
9.35 – 9.45
The Presence of Nutcracker Syndrome in Patients with Ovarian Vein Incompetence
Presenter: Ian Catchpole
9.45 – 9.55
Ovarian Vein Case Studies with Post Coiling Follow Up
Presenter: Kerusha Singh
9.55 – 10.00
Discussion
10:00 – 10:30 am
Morning Tea
10:30 – 12:00 noon
Session B: Vascular Ultrasound in the Treatment of AAA and Beyond

Chairs: K. Weaver, J. Robinson

10.30 – 10.40

Ultrasound – An Effective Tool in EVAR Planning
Presenter: Peter Subramaniam

10.40 – 10.50
Ultrasound and IVUS Findings After the Treatment of AAA with AFX device: The Dark Hole Factor
Presenter: Patrice Mwipitayi
10.50 – 11.00
A Case of Simultaneous Type I, II and III Endoleaks with an Aorto-Caval Fistula
Presenter: Jacqui Robinson
11.00 – 11.10
The Interpretation of Arterial and Venous Waveforms in Patients on ECMO
Presenter: Catherine Kovatch
11.10 – 11.20
Case Study of a Popliteal Artery Saccular Aneurysm with Rupture
Presenter: Stuart Wind
11.20 – 11.30
TCD findings following cerebral AVM resection
Presenter: Kathryn Busch
11.30 – 11.40
Intracranial Embolism via the External Carotid Artery
Presenter: Jenifer Kidd
11.40 – 12.00
Discussion
12:00 noon
Meeting Closes
12:10 – 12:30pm
Lunch
11.00 – 6.00 pm
Registration Desk Open

Venue – Parkside Ballroom Level 2

Verve Symposium: Room 1

12:30 – 2:00pm
Session 1.1: Challenges and New Developments in the Treatment of Femoropopliteal Disease
Chairs: R. Varcoe
Moderators: M. Jaff, P. Schneider, A. Holden, M. Brodmann, F. Fanelli, K. DeLoose
12.30 – 12.35
Introduction
Presenter: Ramon Varcoe
12.35 – 12.43
Endovascular Options for the SFA: What Works and Is there Data to Support it?
Presenter: Brian DeRubertis
12.43 – 12.51
Live Case from POW Sydney – Case 1
12.51 – 12.59
A Head-to-Head Comparison of DCB in the Femoropopliteal Segment
Presenter: Andrew Holden
12.59 – 1.07
Downstream Particulate Effect Seems to Differ Between DCBs – Is This Relevant?
Presenter: Koen DeLoose
1.07 – 1.15
3-year up-date on Drug Eluting Stents in the SFA: The MAJESTIC Trial
Presenter: Stefan Müller-Hülsbeck
1.15 – 1.23
A Real-World Experience with DES: Results from the ZILVER PTX Global Dataset
Presenter: Fabrizio Fanelli
1.23 – 1.31
Live Case from POW Sydney – Case 1 (continued)
1.31 – 1.39
Four-Year Outcomes Using the Heparin-Bonded Viabahn Stent for Long Femoropopliteal Disease
Presenter: Ian Spark
1.39 – 1.47
2-year Results of Stent-Graft Treatment for Patients with Complex Femoropopliteal Lesions in Japan
Presenter: Osamu Iida
1.47 – 1.55
Is There a Role for Direct Oral Anticoagulants After Treatment for PAD?
Presenter: Marianne Brodmann
1.55 – 2.00
Discussion
2:00 – 3:30 pm
Session 1.2: Controversies in Early Clot Removal for Acute DVT
Chairs: M. Jaff, V. Puttaswamy
Moderators: G. O’Sullivan, S. Black, L. Villalba, B. DeRubertis
2.00 – 2.08
Results and Interpretation of the ATTRACT Trial
Presenter: Michael Jaff
2.08 – 2.16
A Review of Clinical Trial Evidence for Aggressive Treatment of Ilio-Femoral DVT
Presenter: Gerard O’Sullivan
2.16 – 2.41
Live Case from POW Sydney – Case 2
2.41 – 2.49
Thrombolysis for DVT: Underutilization of Contemporary Therapy for Deep Venous Thrombosis
Presenter: Brian deRubertis
2.49 – 2.57
Acute Thrombolysis: Who to Treat, When to Treat and What Have the Trials Changed
Presenter: Stephen Black
2.57 – 3.05
Single Session Therapy: Use of the Angiojet Device for Early Clot Removal
Presenter: Laurencia Villalba
3.05 – 3.13
Clot Busting Using Aspiration Thrombectomy with the Penumbra Device – How To Achieve Best Results
Presenter: Sanjay Nadkarni
3.13 – 3.21
Duration of Anticoagulation Therapy After Stenting for Iliofemoral DVT
Presenter: Stephen Merrilees
3.21 – 3.29
Discussion
3.30 – 4.00pm
Afternoon Tea

Venue: Parkside Ballroom

4:00 – 6:00 pm
Session 1.3: Below the Knee Intervention and the Treatment of CLI
Chairs: R. Varcoe, K. DeLoose
Moderators: J. Mustapha, S. Braunlich, P. Goverde, O. Iida
4.00 – 4.08
A Call to Action: The CLI Global Society
Presenter: Jihad Mustapha
4.08 – 4.16
Live Case from Leipzig – Case 3
4.16 – 4.36
The Challenge of Performing Tibial Interventions in the Indigenous Population of Far North Queensland
Presenter: Roxanne Wu
4.36 – 4.44
Is There Any Hope Left for DCB in Infrapopliteal Interventions?
Presenter: Marianne Brodmann
4.44 – 4.52
An Update on the New In.Pact Drug-Coated Balloon Below-the-Knee Trial
Presenter: Yann Goueffic
4.52 – 5.00
Early Results of a New Sirolimus Eluting Stent in BTK Arteries: The Angiolite
Presenter: Peter Goverde
5.00 – 5.08
36-Month Results from the ABSORB-BTK Study
Presenter: Ramon Varcoe
5.08 – 5.16
Towards Optimised BTK Results by Preventing Recoil and Sealing Dissections – TOBA BTK
Presenter: Marianne Brodmann
5.16 – 5.24
Live Case from Leipzig – Case 4
5.24 – 5.40
Prognostic Impact of Revascularizaton versus Conservative Therapy for Poor-Risk CLI Patients
Presenter: Osamu Iida
5.40 – 5.48
The Angiosome Concept: How I Apply it in my Clinical Practice
Presenter: Yann Goueffic
5.48 – 6.00
Discussion

Verve Symposium: Room 2

12:30 – 2:00 pm
Session 2.1: Current Status and Insights into Contemporary AAA Repair
Chairs: M. Thompson, D. Böckler
Moderators: B. Starnes, E. Verhoeven, C. Buckley, J. Matsumura
12.30 – 12.35
Introduction
Presenter: Matt Thompson
12.35 – 12.43
Lessons Learned 15 Years after Completion of the EVAR Trials
Presenter: Jon Matsumura
12.43 – 12.51
Is AAA Volume an Important Consideration for Treatment Threshold?
Presenter: Eric Verhoeven
12.51 – 12.59
Lowering the Threshold for Elective AAA Repair Will Save Lives
Presenter: Matt Thompson
12.59 – 1.07
Endoanchors for the Treatment of Type 1A Endoleak Secondary to Hostile Neck Anatomy During EVAR
Presenter: Dittmar Böckler
1.07 – 1.15
3-D Printed Templates to Facilitate Simplified FEVAR
Presenter: Benjamin Starnes
1.15 – 1.23
Zero Contrast Procedures, Myth or Reality? Pre-Interventional Workup with MR Angiography, Followed by CO2 Angiography
Presenter: Jos van den Berg
1.23 – 1.42
Discussion
DEBATE: We Should Reduce the Threshold for AAA Repair
1.42 – 1.50
FOR the motion: Matt Thompson
1.50 – 1.58
AGAINST the motion: Irwin Mohan
1.58 – 2.00
Vote and Conclude session
2:00 – 3:30 pm
Session 2.2: Scrub in With the Experts: Challenging Aortic Aneurysm Cases
Chairs: F. Criado, E. Verhoeven
Panel: J. Busquet, J. Matsumura, J. May, R. Huilgol
2.00 – 2.08
How NOT to Treat a Ruptured AAA
Presenter: Eric Verhoeven
2.08 – 2.16
Management of a Challenging Aortic Arch Aneurysm in Zone 1
Presenter: Brendan Stanley
2.16 -2.24
Management of a Giant AAA, more than 16cm in Diameter!
Presenter Jacques Busquet
2.24 – 2.32
Trans-Iliac Paraendograft Embolization with Onyx Glue of a Persistent Type II Endoleak
Presenter: Cristina Busoni
2.32 – 2.40
The Case of The Vanishing Endoleak
Presenter: Hani Saeed
2.40 – 2.48
The Challenge of the Accessory Renal Artery
Presenter: Glen Benveniste
2.48 – 2.56
Challenging Case of an Aortic Aneurysm and Simutaneous Repair of a Dissecting Thoracic Aneurysm
Presenter: James May
2.56 – 3.04
‘Aortic Intimal Degloving: A Rare Complication Using TEVAR for Stanford B Aortic Dissection
Presenter: Xuemin Zhang
3.04 – 3.12
In-Situ Arch Fenestration Case with Temporary Bypass Graft Cerebral Perfusion
Presenter: Ravi Huilgol
3.12 – 3.30
Discussion

3:30 – 4:00 pm
Afternoon Tea
Venue: Parkside Ballroom
4:00 – 6:00 pm
Session 2.3: What’s Wrong with EVAR and How Can it be Improved?
Chairs: F. Criado, M. Thompson
Moderators: F. Fanelli, D. Böckler, P. Puckridge, V. Puttaswamy
Supported by: Getinge
4.00 – 4.08
The Injustice of Recognizing One Person for a Landmark Invention or Contribution While Ignoring Others and the Circumstances That Made it Possible in the First Place: The Myth of the Lone Pioneer
Presenter: Frank Criado
4.08 – 4.28
Live Case From POW Sydney – Case 5
4.28 – 4.36
Can the Long-Term Data from Clinical Trials Justify the Generalised Application of EVAR?
Presenter: Fabrizio Fanelli
4.36 – 4.44
Does EVAR Cause Long Term Cancer Mortality due to Radiation Exposure?
Presenter: Matt Thompson
4.44 – 4.52
Fusion Guided Imaging for EVAR/TEVAR has the Potential to Facilitate Safety and Efficiency
Presenter: Ravi Huilgol
4.52 – 5.00
The Use of the Aortic AFX Graft to Treat the Diseased, Embologenic Aorta
Presenter: Phillip Puckridge
5.00 – 5.20
Live Case From POW Sydney – Case 5 (continued)
5.20 – 5.28
The Place for Open Aortic Aneurysm Repair in 2017
Presenter: Dittmar Böckler
5.28 – 5.36
Could Diabetes Hold the Key to a Medical Solution for AAA?
Presenter: Jonathan Golledge
5.36 – 5.44
Discussion
DEBATE: Longterm Results from Clinical Trials Prove that EVAR is a Failed Experiment
FOR the motion: TBC
AGAINST the motion: Dittmar Böckler
5.44 – 5.52
FOR the motion
Presenter: Andrew Holden
5.52 – 6.00
AGAINST the motion
Presenter: Dittmar Böckler
6.00
Vote and Conclude Session
6:00 pm
Close of Day 1
6:00 – 7:30 pm
Welcome Reception
Venue: Parkside Ballroom

Friday 8 December Day 2: Venue: Parkside Ballroom – Level 2

7:00 am – 6:00 pm
Registration Desk Open
Venue – Parkside Ballroom Level 2
7:00 am – 7:50 am
Breakfast Session

Venue: Room 2

Breakfast Session

Moderator: Prakash Saha

Supported by Philips Volcano and Life Healthcare

The value of IVUS in Endovenous Procedures
Moderator: Prakash Saha

Introduction
Presenter: Prakash Saha
IVUS When and How – Where does IVUS have a role ?
Presenter: Steve Dubenec
My experience with IVUS in iliofemoral venous stenting
Presenter: Patrick Tosenovsky
VIDEO Trial Results
Presenter: Prakash Saha
Discussion and Questions
Presenter: Panel

Verve Symposium: Room 1

8:00 – 9:30 am
Session 1.4: Combination Therapy in the Periphery
Chairs: K. DeLoose, B. DeRubertis
Moderators: M. Brodmann, R. Sachar, P. Mwipatayi
Supported by: Abbott Vascular
8.00 – 8.08
Can a Bare Metal Stent and DCB Combination Give Superior Results to Either Alone? The DEBAS Trial
Presenter: Patrice Mwipitayi
8.08 – 8.16
Economic Analysis of SFA Interventions – Angioplasty, Standard Nitinol Stents, Interwoven Stents, and DCB
Presenter: Brian DeRubertis
8.16 – 8.24
Can the Use of Supera with Drug Coated Balloon Improve Results Compared with Stent Alone?
Presenter: Peter Goverde
8.24 – 8.54
Live Case from Leipzig – Case 6
8.54 – 9.02
Is There a Place for Lithoplasty to Dirsupt Calcium and Assist Drug Transfer with DCB?
Presenter: Marianne Brodmann
9.02 – 9.10
Combination Therapy with Atherectomy: The Solution for Complex Lesions?
Presenter: Ravish Sachar
9.10 – 9.18
12-Month Results of the Biolux4Ever Trial Combining Bare Metal Stent with DCB
Presenter: Koen DeLoose
9.18 – 9.26
Combining Common Femoral Endarterectomy with Peripheral Intervention: Bespoke Hybrid Surgery is the Best of Both World
Presenter: Andrew Hill
9.26 – 9.30
Discussion
9:30 – 11:00 am
Session 1.5: Technical Success and Durability for the SFA
Chairs: I. Spark, J. Mustapha
Moderators: S. Müller-Hülsbeck, S. Braunlich, G. Goh, B. Beasley
Supported by: Bard
9.30 – 9.38
How Should we Define Success for SFA Interventions? What are the Limitations of TLR and Patency Endpoints
Presenter: Stefan Müller-Hülsbeck
9.38-10.00
Live Case from MAT Sydney – Case 8
10.00 – 10.08
How to Manage the Long and Severely Calcified SFA CTO – From A to Z
Presenter: Jihad Mustapha
10.08 – 10.16
Techniques and Technologies to Maximize your Chances of Success Crossing Difficult CTOs
Presenter: Ian Spark
10.16 – 10.30
Live Case from MAT Sydney – Case 8 (continued)
10.30 – 10.38
An Australian Based Cost Analysis Comparing the Use of Drug Coated Balloons and Drug Eluting Stents in Patients with PAD
Presenter: Gerard Goh
10.38 – 10.46
An Update on Lutonix DCB Data for Treatment of the SFA
Presenter: Sven Braunlich
10.46 – 11.00
Discussion
11:00 – 11:30 am
Morning Tea
Venue: Parkside Ballroom
11:30 – 1:00 pm
Session 1.6: Deep Venous Stenting
Chairs: M. Jaff, S. Black
Moderators: G. O’Sullivan, B. DeRubertis, R. Tripathi
Supported by: Bard
11.30 – 11.38
May-Thurner Syndrome: From Swollen Legs to DVT, Pathways of Care to Define Our Approach to Intervention
Presenter: Michael Jaff
11.38 – 11.46
Preoperative Imaging for Ilio-Femoral Venous Obstruction
Presenter: Gerard O’Sullivan
11.46 – 12.10
Live Case from MAT Sydney – Case 10
12.10 – 12.18
Individualising Your Patient’s Anatomy to the Attributes of Dedicated Venous Stents
Presenter: Ramon Varcoe
12.18 – 12.26
Devices and Techniques for Deep Venous Recanalization
Presenter: Brian DeRubertis
12.26 – 12.34
Stenting Under the Inguinal Ligament – Strategies for Stent Choice and Patient Selection
Presenter: Stephen Black
12.34 – 12.42
Post-thrombotic Iliac and Femoral Vein Obstruction – Strategies Beyond Iliac Vein Stents
Presenter: Ramesh Tripathi
12.42 – 12.50
An Australian Experience with the New Venovo Dedicated Venous Stent
Presenter: Steven Dubenec (via satellite)
12.50 – 1.00
Discussion

Verve Symposium: Room 2

8:00 – 9:30 am
Session 2.4: Challenges in the Treatment of Superficial Venous Disease and Truncal Reflux
Chairs: S. Thomas, M. Malouf
Moderators: S. Roberts, N. Ibrahim, D. Huber, E. Macauley, G. Benveniste
8.00 – 8.07
From Thermal Ablation to Cyanoacrylate: Achieving Complete Care in an Ambulatory Setting
Presenter: Nabeel Ibrahim
8.07 – 8.28
Live Case from POW Sydney – Case 7
8.28-8.35
Lessons Learned and Results Using Venaseal as an Early Adopter
Presenter: Shannon Thomas
8.35 – 8.43
Latest Updates On Endovenous Laser for the Treatment of Truncal Vein Insufficiency
Presenter: Sanjay Nadkarni
8.43 – 8.50
The Relevance of the Anterolateral Thigh Vein and Management Option
Presenter: Peter Subramniam
8.50 – 8.57
Sclerotherapy, Cutaneous Lasers and Cyanoacrylate – Which Modality to use for Reticular and Telangiectatic Veins of the Lower Limb
Presenter: Stefania Roberts
8.57 – 9.04
Calf DVT After Venous Ablation – To Treat or Not to Treat?
Presenter: Abdullah Omari
9.04 – 9.11
The Relationship Between Lower Extremity Reflux and Distant Venous Compression Syndromes
Presenter: David Huber
9.11 – 9.18
Treatment options for the Small Saphenous Vein
Presenter: Mark Malouf
9.18 – 9.25
Minimally Invasive Venous Treatment in the Public Hospital System
Presenter: Matthew Claydon
9.25 – 9.30
Discussion
9:30 – 11:00 am
Session 2.5: More Venous Topics – Pelvic Congestion, IVC and PE Management
Chairs: M. Jaff, J. Van den Berg
Moderators: G. O’Sullivan, L. Villalba, J. Busquet, L. Baker
9.30 – 9.38
The Prevalence of Pelvic Vein Reflux and Criteria for Treatment
Presenter: Laurencia Villalba
9.38 – 9.46
Embolisation Options in the Treatment of Pelvic Congestion Syndrome and Varicocoele
Presenter: Gerry O’Sullivan
9.46 – 10.16
Live Case from POW Sydney – Case 9
10.16 – 10.24
Contemporary Management of Venous Thoracic Outlet Syndrome
Presenter: Jacques Busquet
10.24 – 10.32
Step-by-step Technique for Difficult IVC Filter Retrieval
Presenter: Brian DeRubertis
10.32 – 10.40
Vena Cava Filters – Time to Place, and Time to Retrieve – Are the Indications Clear?
Presenter: Michael Jaff
10.40 – 10.48
The Development of a Pulmonary Embolus Response Team: Challenges and Results So Far
Presenter: Luke Baker
10.48 – 11.00
Discussion
11:00 – 11:30 am
Morning Tea

Venue: Parkside Ballroom

11:30 – 1:00 pm
Session 2.6: Current Concepts and Updates for the Future of Carotid Intervention
Chairs: P. Schneider, J. Matsumura
Moderators: S. Müller-Hülsbeck, F Criado, B. Stanley
11.30 – 11.38
5-Year Results from the ACT-1 Trial: CAS vs CEA in Asymptomatic Patients
Presenter: Jon Matsumura
11.38 – 11.46
Closed Cell versus Dual Layer Carotid Stent Design – Are There Differences in Clinical Outcome?
Presenter: Stefan Müller-Hülsbeck
11.46 – 11.54
Results from the SCAFFOLD Study of the Gore PTFE-Mesh Covered Carotid Stent
Presenter: Peter Schneider
11.54 – 12.04
The Type 3 Aortic Arch is NOT a Contraindication to CAS
Presenter: Bernard Bourke
12.04 – 12.12
The Rapid Emergence of Transcervical Access for CAS: Will CEA Finally be Dethroned?
Presenter: Frank Criado
12.12 – 12.20
Is Transcervical CAS a Useful Technique or Simply for Those Less Skilled at Catheter Intervention?
Presenter: Brian Derubertis
12.20 – 12.28
Integrated Embolic Protection Technology – Double Filtration During Carotid Artery Stenting 
Presenter: Ravish Sachar
12.28 – 12.42
Discussion
DEBATE: The Development of Dual Layer Micromesh Stents and Transcervical Access Represent the Future of Carotid Intervention, Sure to Surpass CEA
12.42 – 12.50
FOR the motion: Peter Schneider
Presenter: Peter Schneider
12.50 – 12.58
AGAINST the motion: Andrew Hill
12.58 – 1.00
Vote and Conclude Session
1:00 – 2:00 pm
Lunch
1:00 – 2:00 pm
Lunch Session

Venue: Room 2

Supported by: Bard Australia

Title: Future of Deep Venous Care

Facilitator: Jihad Mustapha

An interview with Dr Gerard O’Sullivan, MD – who will share his expertise and make predictions on the future

Verve Symposium: Room 1

2.00 – 3.30 pm
Session 1.7: Juxta-Renal Aneurysms & the Hostile Infra-Renal Neck
Chairs: E. Verhoeven, D. Böckler
Moderators: A. Lennox, F. Criado, B. Starnes, P. Mwipatayi
Supported by: Medtronic
2.00 – 2.08
5-years Results from the ENGAGE Registry: Long term Outcome in the Octogenarian Population
Presenter: Patrice Mwipitayi
2.08 – 2.30
Live Case from MAT Sydney – Case 11
2.30 – 2.38
Endoanchors: Only for Bailout or Should They be Routine?
Presenter: Andrew Lennox
2.38 – 2.46
Is There a Real Difference Between 3-4 Vessel Fenestrated Cases and Those With 1-2?
Presenter: Eric Verhoeven
2.46 – 2.54
The Use of Fusion Software and Dyna CT to Facilitate Fenestrated EVAR
Presenter: Dittmar Böckler
2.54 – 3.00
Live Case from MAT Sydney – Case 11 (continued)
3.00 – 3.08
Type 1 Endoleaks Do Not Exist with Properly Planned FEVAR – “The Concept of Effective Seal Zone”
Presenter: Benjamin Starnes
3.08-3.16
The Australian and New Zealand Experience with Endoanchors for the Hostile Neck (via satellite)
Presenter: Vik Puttaswamy
3.16 – 3.18
Discussion
DEBATE: FEVAR Will Always be Superior to ChEVAR for the Short Neck
3.18 – 3.24
FOR the motion: Eric Verhoeven
3.24 – 3.30
AGAINST the motion: Frank Criado
3.30
Vote and Conclude Session
3:30 – 4:00 pm
Afternoon Tea

Venue: Parkside Ballroom

4:00 – 6:00 pm
Session 1.8: Challenges in the Thoracic Aorta
Chairs: M. Thompson, F. Criado
Moderators: D. Böckler, E. Verhoeven, A. Holden, T. Vasudevan, B. Stanley
Supported by: WL Gore
THORACIC DISSECTION
4.00 – 4.08
The Use of Early TEVAR for the Treatment of Type B Aortic Dissection – Where is it Indicated?
Presenter: Dittmar Böckler
4.08 – 4.16
TEVAR for Type B Aortic Dissection with “Radiologic Malperfusion” (collapsed true lumen): Can this be supported with evidence?
Presenter: Frank Criado
4.16 – 4.20
Discussion – Can we agree on the high-risk indications for uncomplicated TBAD and the best timing?
4.20 – 4.24
Discussion – Are all dissections complicated?
4.24 – 4.32
A Difficult Case of Persistent False Lumen Following TEVAR with Novel Use of Inverted Aorto-Uni-Iliac Converter
Presenter: Shane Belveder
4.32 – 4.40
Management of the False Lumen in Chronic Aortic Dissection
Presenter: Andrew Holden
4.40 – 4.48
The Treatment of Chronic Type B Aortic Dissection with Fenestrated and Branched Devices: Long-Term Results
Presenter: Eric Verhoeven
4.48 – 5.00
Discussion – The emerging role of false lumen treatment in managing chronic dissection
THE AORTIC ARCH
5.00 – 5.08
5-Year Results for the Gore C-Tag Device in Treating Thoracic Aneurysm
Presenter: Dittmar Böckler
5.08 – 5.16
Stroke Prevention Solutions for Aortic Arch Endografting: What is on the Horizon?
Presenter: Brendan Stanley
5.16 – 5.21
Discussion – Stroke prevention in aortic arch endografting. What is likely to work?
5.21 – 5.26
Discussion – Does Current New Technology Get Us All the Way to the Valve? Or, What are the
Unmet Needs We Need to Focus On?
5.26 – 5.34
In-situ fenestration and proximal scallops in the treatment of disease in the aortic arch
Presenter: Jos van den Berg
5.34 – 5.42
Advanced Branch and Fenestrated Endograft Options for Complete Endovascular Treatment of the Aortic Arch
Presenter: Thodur Vasudevan
5.42 – 5.50
Discussion – Endografting the arch. What are the winning platforms?
5.50 – 6.00
Discussion – Is it still too early to tell?

Verve Symposium: Room 2

2:00 – 3:30 pm
Session 2.7: New Concept in Dialysis Access Intervention
Chairs: J. Swinnen, S. Kum
Moderators: G. Goh, D. Huber, P. Goverde, J. van den Berg
2.00 – 2.08
Methods to Improve Patency After Dialysis Access Intervention
Presenter: Jos van den Berg
2.08 – 2.16
The Role of Drug Coated Balloons in the AV Fistula
Presenter: Gerard Goh
2.16 – 2.26
Results of a Blinded, Randomised, Multicentre Trial Comparing Drug Eluting Balloons with Plain Balloons in the Native AVF
Presenter: John Swinnen
2.26 – 2.46
Live Case from POW Sydney – Case 12
2.46 – 2.54
Flow Dynamics and 3-D Modelling of the AV Fistula at the Bedside May Translate to Better Care
Presenter: John Carroll
2.54 – 3.02
Forced Maturation of the Arteriovenous Fistula Using Adjuvant Stent Placement
Presenter: Anoosha Aslam
3.02 – 3.10
Novel Use of the Clarivein Catheter for Pharmacomechanical Thrombolysis of Haemodialysis Grafts
Presenter: Steven Kum
3.10 – 3.18
Using the Supera Interwoven Nitinol Stent to Treat the Juxta-Anastomotic AV Fistula Stenosis
Presenter: Shannon Thomas (via satellite)
3.18 – 3.30
Discussion
3:30 – 4:00 pm
Afternoon Tea

Venue: Parkside Ballroom

4:00 – 6:00 pm
Session 2.8: Peripheral Intervention Challenging Traditional Surgical Zones
Chairs: R. Varcoe, K. DeLoose
Moderators: Y. Goeffic, P. Goverde, P Schneider, M. Brodmann
4.00 – 4.08
How the “No-Stent Zones” Policy has Become Obsolete and Unnecessary in the Age of Novel Stent Technology and Swirling Blood Flow
Presenter: Frank Criado
4.08 – 4.33
Live Case from Leipzig – Case 13
4.33 – 4.41
DCB May be the Treatment of Choice for the Popliteal Artery – Insights from the IN.PACT Flexion Study
Presenter: Koen DeLoose
4.41 – 4.48
What is the Evidence for Endovascular Treatment of the Popliteal Artery?
Presenter: Peter Schneider
4.48 – 4.56
2-Year Results from the TECCO Trial: An RCT Comparing Stenting to Open Surgery for Common
Femoral Artery Stenosis
Presenter: Yann Goueffic
4.56 – 5.20
Live Case from Leipzig – Case 14
5.20 – 5.28
Stenting of the Common Femoral Artery: Is it Feasible and What is the Best Technique?
Presenter: Peter Goverde
5.28 – 5.36
Shockwave Lithoplasty May be an Option for Treatment of the Common Femoral Artery
Presenter: Marianne Brodmann
5.36 – 5.44
Latest Results from the ZILVERPASS Study: An RCT Comparing DES to Fem-Pop Bypass
Presenter: Koen KeLoose
5.44 – 6.00
Discussion
7:30 – 11:00 pm
Symposium Dinner

Venue: Dockside Cockle Bay Darling Harbour

Supported by: WL Gore

Saturday 9 December Day 3: Venue: Parkside Ballroom – Level 2

7:00 am – 6:00 pm
Registration Desk Open

Venue – Parkside Ballroom Level 2

Verve Symposium: Room 1

8:00 – 9:30 am
Session 1.9: The Current State of Anti-Restenotic Therapy for the SFA
Chairs: P. Schneider, R. Sachar
Moderators: I. Spark, K. DeLoose, F. Fanelli
Supported by: Medtronic
8.00 – 8.08

IN.PACT Global Registry 2 Year Results Update
Presenter: Michael Jaff

8.08 – 8.38

Live Case from Leipzig – Case 15

8.38 – 8.46

IN.PACT SFA 4 Year Results Update
Presenter: Peter Schneider

8.46 – 8.54
Antirestenotic therapy: Is the DCB the new standard of care in the SFA?
Presenter: Fabrizio Fanelli
8.54 – 9.02

Drug Coated Balloon Angioplasty in Long Femoropopliteal Lesions: 2-Year Results with Medtronic IN.PACT Admiral
Presenter: Ian Spark

9.02 – 9.10

Scaffolds: Is There a Place for Stents in the Era of DCB?
Presenter: Koen DeLoose

9.10 – 9.18

Vessel Preparation: What, When and Where is it Needed?
Presenter: Ravish Sachar

9.18 – 9.30

Discussion

9:30 – 11:00 am
Session 1.10: Below-the-Knee and Retrograde Interventions
Chairs: S. Kum, J. Mustapha
Moderators: M. Brodmann, B. DeRubertis, J. van den Berg, K. DeLoose
Supported by: Cook Medical
9.30 – 9.38

What is the Evidence for an “Endovascular-First” Approach to CLI
Presenter: Yann Goueffic

9.38 – 9.58

Live Case from Leipzig – Case 17

9.58 – 10.06

Technique and Devices for Retrograde Access
Presenter: Brian DeRubertis

10.06 – 10.14

Tips and Tricks for Pedal Access: From Set-Up to Managing Your Access…How to Get Started
Presenter: Jos van den Berg

10.14 – 10.22

OK, I Have Bi-Directional Access but I Can’t Get Through…What to do Next?
Presenter: Koen DeLoose

10.22 – 10.30

12-Month Results from the Lutonix BTK Trial
Presenter: Jihad Mustapha

10.30 – 10.38

The Soundbite Guidewire as a New CTO Guidewire for Crossing Calcified CTO´s
Presenter: Marianne Brodmann

10.38 – 10.46

When is below-the-ankle angioplasty indicated and how to introduce it into your practice?
Presenter: Peter Schneider

10.46 – 11.00

Discussion

11:00 – 11:30 am
Morning Tea

Venue: Parkside Ballroom

11:30 – 1:00 pm
Session 1.11: The Endovascular Treatment of Ruptured AAA
Chairs: E. Verhoeven, B. Starnes
Moderators: M. Thompson, J. Matsumura, D. Böckler, J. Iliopoulos
11.30 – 11.38
A Tribute to the Late Dr Clifford Buckley
Presenter: Jacques Busquet
11.38 – 11.46

What is the Best Option for Emergency AAA Repair in 2017
Presenter: Jim Iliopolous

11.46 – 11.54

Experience with Over 300 Ruptured AAA – Lessons Learned
Presenter: Benjamin Starnes

11.54 – 12.24

Live Case from POW Sydney – Case 18

12.24 – 12.32

Systems Improving Care for Aortic Emergencies: The University of Wisconsin Way
Presenter: Jon Matsumura

12.32 – 12.40

Latest Results from the IMPROVE (Ruptured AAA) Study
Presenter: Matt Thompson

12.40-12.50

Experience of a Vascular Surgeon in the Mass Casualty Environment
Presenter: John Swinnen

12.50 – 1.00

Discussion

Verve Symposium: Room 2

8.00 – 9.30 am
Session 2.9: Current and Emerging Embolisation Techniques
Chairs: A. Holden, S. Müller-Hülsbeck
Moderators: J. Busquet, L. Baker, B. Beasley
8.00 – 8.08

The ABC’s of Embolisation Technique: All You Need to Know
Presenter: Luke Baker

8.08 – 8.30

Live Case from POW Sydney – Case 16

8.30 – 8.38

Endovascular Techniques for Visceral Artery Aneurysm Treatment
Presenter: Stefan Müller-Hülsbeck

8.38 – 8.46

Endovascular Management of Symptomatic Coeliac Artery Aneurysms
Presenter: Jacques Busquet

8.46 – 8.54

The Miniaturistion of Vascular Occlusion Plugs: How this Can Assist Our Practice
Presenter: Stephen Merrilees

8.54 – 9.02

Direct Sac Puncture for Type II Endoleak: How I do it, Tips and Tricks
Presenter: Fabrizio Fanelli

9.02 – 9.10

State of the Art Treatment Options for Primary Liver Malignancies and Metastatic Disease
Presenter: Luke Baker

9.10 – 9.18

New Frontiers in Embolization Therapy: Interventional Treatment for Prostatism, Fibroids and even Obesity
Presenter: Bob Beasley

9.18 – 9.30

Discussion

9:30 – 11:00 am
Session 2.10: Strategic Directions in the Battle Against Abdominal Aortic Aneurysm Disease

Chairs: E. Verhoeven

Panellists: M. Thompson, B. Starnes, J. Matsumura, D. Böckler, P. Schneider

9.30 – 9.45

Case 1 – Verhoeven

9.45 – 10.00

Case 2 – Schneider

10.00 – 10.15

Case 3 – Thompson

10.15 – 10.30

Case 4 – Starnes

10.30 – 10.45

Case 5 – Matsumura

10.45 – 11.00

Case 6 – Böckler

11:00 – 11:30 am
Morning Tea

Venue: Parkside Ballroom

11:30 – 1:00 pm
Session 2.11 Advanced Venous Concepts and My Worst Venous Disaster…Lessons Learned and How to Avoid them in Your Practice!
Chairs: G. O’Sullivan, M. Malouf
Moderators: S. Black, E. Macauley, P. Charalabidis
11.30 – 11.38

Pharmacological Management of Patients After Venous Stenting – Strategies to Prevent Stent Thrombosis
Presenter: Stephen Black

11.38 – 11.46

Technical Tips and Tricks for Iliofemoral Venous Obstruction
Presenter: Gerard O’Sullivan

11.46 – 11.54

Cautionary Tales from the Removal of IVC Filters – I Hope That Never Happens to Me!
Presenter: Perter Charalabidis

11.54 – 12.02

Management of Acute Iliofemoral DVT with Catheter Directed Pharmacomechanical Thrombolysis (Angiojet): A Multicentre Evaluation
Presenter: Gurkirat Singh

12.02 – 12.10

My Biggest Venous Disaster…from Sydney
Presenter: Mark Malouf

12.10 – 12.18

My Biggest Venous Disaster…from London
Presenter: Stephen Black

12.18 – 12.26

My Biggest Venous Disaster…from Adelaide
Presenter: Ewan Macauley

12.26 – 12.34

My Biggest Venous Disaster…from Galway
Presenter: Gerard O’Sullivan

12.34 – 1.00

Discussion

1:00 – 2:00 pm
Lunch
1:00 – 2:00 pm
Lunch Session
1.00 – 2.00
Sponsored Lunch Session
Vessel Preparation and its Pivotal Role Towards Maintaining Flow
Chairs: A. Holden
Moderators: R. Sachar, V. Puttaswamy, F. Fanelli
Supported by: Medtronic
13.10 – 13.15
Welcome and Overview
Presenter: Andrew Holden
13.15 – 13.25
Calcium Effects on Vessel Preparation
Presenter: Fabrizio Fanelli
13.25 – 13.40
Vessel Prep, What, When are Where is it Needed
Presenter: Ravish Sachar
13.40 – 13.50
Hawk and the Australian Experience
Presenter: Vik Puttaswamy
13.50 – 14.00
Discussion

Verve Symposium: Room 1

2.00 – 3.30 pm
Session 1.12: Aorto-Iliac Occlusive Disease
Chairs: P. Mwipatayi
Moderators: P. Goverde, S. Thomas, Y. Goueffic, O. Iida
Supported by: Gore
2.00 – 2.08

Current Status and Evolution of the CERAB Technique: Where are we in 2017?
Presenter: Peter Goverde

2.08 – 2.38

Live Case from POW Sydney – Case 19

2.38 – 2.46

The Place for Covered Stents, DCB and Open Surgery in Aorto-Iliac Disease: What is the Evidence?
Presenter: Sven Braunlich

2.46 – 2.54

Balloon Expandable Covered Stents in Arterial Interventions – Suddenly a Crowded Space!
Presenter: Andrew Holden

2.54 – 3.02

The Role of Lithoplasty in Iliac Arteries
Presenter: Fabrizio Fanelli

3.02 – 3.10

Successful of Hybrid Revascularization for TASC D Aorto-Iliac Disease after Failing Femoro-Femoral Crossover Bypass
Presenter: Jaroen Cheewinmethasiri

3.10 – 3.18

The Use of Viabahn Stent-Grafts to Treat Aortoiliac Occlusive Disease
Presenter: Shannon Thomas (via satellite)

3.18 – 3.30

Discussion

3:30 – 4:00 pm
Afternoon Tea
Venue: Parkside Ballroom

4:00 – 6:00 pm
Session 1.13: Complex Peripheral Challenges
Chairs: R. Varcoe
Moderators: S. Muller Hulsbeck, S. Braunlich, S. Kum, F. Fanelli, D. Robinson
4.00 – 4.08

Crossing Catheter Technology: What to Turn to When You Can’t Get Through That Lesion
Presenter: Yew-Ming Kuan

4.08 – 4.35

Live Case from Leipzig – Case 20

4.35 – 4.43

Retrograde Tibial Access – A “New” Approach for SFA Recanalization
Presenter: Fabrizio Fanelli

4.43 – 4.51

Vessel Preparation is Key to Success: An Old Forgotten Concept, Now Reinvented
Presenter: Sven Braunlich

4.51 – 4.59

The BATTLE Trial: Comparing Bare Metal to Drug Eluting Stents for Intermediate Length Lesions of the SFA
Presenter: Yann Goueffic

4.59 – 5.07

Japanese One-Year Results for DCB Treatment in patients with Femoropopliteal Occlusive Disease
Presenter: Osamu Iida

5.07 – 5.15

“Crush Stenting” An Alternative Approach to Manage Occluded Femoropopliteal Stents
Presenter: Stefan Müller-Hülsbeck

5.15 – 5.23

EffPac-Trial: Effectiveness of LUMINOR® DCB versus POBA in the SFA: primary endpoint and 6 months results
Presenter: Ulf Teichgraber

5.23 – 5.35

Live Case from Leipzig – Case 21

5.35 – 5.43

Safety and Durability of 4F SFA Stenting in the Outpatient Setting: A 10 year experience with Long-Term Follow-Up
Presenter: Jos van den Berg

5.43 – 5.51

The Use of Angiojet and Jetstream Thrombectomy Systems in Peripheral Applications
Presenter: Mathew Sebastian

5.51 – 5.59

Predictive Factors in Minor Amputation Healing: How to Choose Who to Revascularise
Presenter: Domenic Robinson

Discussion

Verve Symposium: Room 2

2:00 – 3:30 pm
Session 2.12: Future Technological Development in the Treatment of Vascular Disease
2.00 – 2.10

Future Technologies to Deal with the Short Aortic Neck
Presenter: Randy Bassett

2.10 – 2.20

Novel Nano-Polymers May be Useful for SFA Stents
Presenter: Glen Benveniste

2.20 – 2.30

A Complete Approach to Stentgraft Therapy for the Entire Aorta
Presenter: Dittmar Böckler

2.30 – 2.40

What Does the Future Hold for the Training of Endovascular Skills?
Presenter: Tony Freeman

2.40 – 2.50

Polymer Technology and the Future of Aortic Surgery
Presenter: Matt Thompson

2.50 – 3.00

Next generation DES for the Periphery
Presenter: Kian Olsen

3.00 – 3.10

Novel Therapeutic Approaches for Claudication and CLI with Recombinant Human Elastase
Presenter: Jihad Mustapha

3.10 – 3.20

The Future of Amputation Prevention Across Australia
Presenter: Greg Johnson

3.20 – 3.30

Discussion

3.30 – 4.00pm
Afternoon Tea

Venue: Parkside Ballroom

4:00 – 6:00 pm
Session 2.13: Challenging Cases: Aortic and Beyond
Chairs: A. Bray, B. Bourke
Moderators: A. Lennox, V. Bourke, V. Puttaswamy
4.00 – 4.08

Modified Viabahn Open Revascularisation Technique (VORTEC) to Facilitate Trans-Aortic Right Renal Artery Revascularisation in Hybrid Thoracoabdominal
Presenter: Andrew Hattam

4.08 – 4.16

TEVAR to the False Lumen of a Chronic Type B Aortic Dissection with Aneurysmal Dilatation When There are no Other Options: A Novel Technique
Presenter: Samer Koussayer

4.16 – 4.24

Emergency Endovascular Repair for Acute Traumatic Thoracic Aortic Transection
Presenter: Xiu Pin

4.24 – 4.32

Risk Factors and Early Outcomes of Acute Renal Injury After Thoracic Aortic Endograft Repair for Type B Aortic Dissection
Presenter: Yingcong Liang

4.32 – 4.40

Management of Renal Artery Dissection Post Early EVAR for Salmonella Aortitis
Presenter: Kejia Wang

4.40 – 4.48
Experience with Complications During Endovascular Therapy for Aorto-Iliac Occlusive Disease
Presenter: Ming Qi
4.48 – 4.56

Novel Treatment for a Rare Case of Bilateral Internal Mammary Artery Aneurysms
Presenter: Kejia Wang

4.56 – 5.04

Treatment of an Abdominal Aortic Pseudoaneurysm with EVAS Following Previous Open Repair
Presenter: Cassandra Jeavons

5.04 – 5.12

Open Surgery and Endovascular Management in Patients with Takayasu Arteritis: An 11-year Experience
Presenter: Yongjun Li

5.12 – 5.20

Multimodality Imaging of a Hemiazygos Continuation of a Left Sided Inferior Vena Cava
Presenter: Luis Arturo Lunares Dueñas

5.20 – 5.28

Endovascular Solution in a Case of Abdominal Aortic Dissection with Bilateral Lower Limb Ischemia in a Man Trampled by a Bull.
Presenter: Jaroen Cheewinmethasiri

5.28 – 5.36
Penetrating Popliteal Injury – A Novel Endovascular Approach To Repair A Traumatic Popliteal Pseudoaneurysm and Arteriovenous Fistula
Presenter: Aman Williams
5.36 – 6.00

Discussion

6:00 pm
Close of Symposium